Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA
Plaintiff / Appellant: AMARIN PHARMACEUTICALS IRELAND LIMITED and AMARIN PHARMA, INC.
Defendant / Appellee: DR. REDDY'S LABORATORIES, LTD., WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED, DR. REDDY'S LABORATORIES, INC., HIKMA PHARMACEUTICALS USA INC. and HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED
Amicus Curiae: AIMED ALLIANCE and BIOTECHNOLOGY INNOVATION ORGANIZATION
Case Number: 20-1723
Filed: April 21, 2020
Court: U.S. Court of Appeals, Federal Circuit
Nature of Suit: Other

Opinions

We have the following opinions for this case:

Date Filed Description
September 3, 2020 AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA

Docket Report

This docket was last retrieved on June 16, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
June 16, 2020 Filing 49 FILED from Appellees Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc., Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Title: RESPONSE BRIEF. Service: 06/16/2020 by email. (PENDING COMPLIANCE REVIEW) [701700] [20-1723] [Charles Klein] [Entered: 06/16/2020 11:44 PM]
June 16, 2020 Filing 48 Amended Certificate of Interest for Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 06/16/2020 by email. [701691] [20-1723] [Charles Klein] [Entered: 06/16/2020 09:36 PM]
June 16, 2020 Filing 47 Amended Certificate of Interest for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 06/16/2020 by email. [701681] [20-1723] [Constance Huttner] [Entered: 06/16/2020 06:48 PM]
May 20, 2020 Filing 46 MODIFIED ENTRY: CORRECTED AMICUS BRIEF FILED for Biotechnology Innovation Organization. Pages: 19. Service: 05/20/2020 by email. [696016]--[Edited 05/21/2020 by LMN - compliance review complete] [Rachel Elsby] [Entered: 05/20/2020 06:18 PM]
May 20, 2020 Filing 45 Notice of Correction to Doc No. [ # 43 ] for Amicus Curiae Biotechnology Innovation Organization. Service: 05/20/2020 by email. [696015] [20-1723] [Rachel Elsby] [Entered: 05/20/2020 06:14 PM]
May 20, 2020 Filing 44 NOTICE OF NON-COMPLIANCE: The submission of Amicus Curiae Biotechnology Innovation Organization, Amicus Curiae Brief [ # 39 ], is not in compliance with the rules of this court (see attached). Compliant document is due on 05/28/2020. Service as of this date by the Clerk of Court. [695988] [LMN] [Entered: 05/20/2020 04:16 PM]
May 19, 2020 Filing 43 MODIFIED ENTRY: AMICUS BRIEF FILED for Aimed Alliance. Pages: 26. Service: 05/19/2020 by email. [695791]--[Edited 05/20/2020 by LMN - compliance review complete] [Ashley Parrish] [Entered: 05/19/2020 06:28 PM]
May 19, 2020 Filing 42 Entry of appearance for Jesse Snyder as of counsel for Aimed Alliance. Service: 05/19/2020 by email. [695786] [20-1723] [Jesse Snyder] [Entered: 05/19/2020 06:22 PM]
May 19, 2020 Filing 41 Entry of appearance for Paul Alessio Mezzina as of counsel for Aimed Alliance. Service: 05/19/2020 by email. [695785] [20-1723] [Paul Mezzina] [Entered: 05/19/2020 06:18 PM]
May 19, 2020 Filing 40 Certificate of Interest for Aimed Alliance. Service: 05/19/2020 by email. [695782] [20-1723] [Ashley Parrish] [Entered: 05/19/2020 05:59 PM]
May 19, 2020 Filing 39 FILED from Biotechnology Innovation Organization Title: AMICUS CURIAE BRIEF. Service: 05/19/2020 by email. (PENDING COMPLIANCE REVIEW) [695781] [20-1723] This document is non-compliant. See Doc No. [ # 44 ] [Rachel Elsby] [Entered: 05/19/2020 05:59 PM]
May 19, 2020 Filing 38 Entry of appearance for Ashley C. Parrish as principal counsel for Aimed Alliance. Service: 05/19/2020 by email. [695780] [20-1723] [Ashley Parrish] [Entered: 05/19/2020 05:57 PM]
May 19, 2020 Filing 37 Entry of appearance for Hans Sauer as of counsel for Biotechnology Innovation Organization. Service: 05/19/2020 by email. [695779] [20-1723] [Rachel Elsby] [Entered: 05/19/2020 05:48 PM]
May 19, 2020 Filing 36 Entry of appearance for Melissa Brand as of counsel for Biotechnology Innovation Organization. Service: 05/19/2020 by email. [695778] [20-1723] [Rachel Elsby] [Entered: 05/19/2020 05:43 PM]
May 19, 2020 Filing 35 Entry of appearance for Jason Weil as of counsel for Biotechnology Innovation Organization. Service: 05/19/2020 by email. [695776] [20-1723] [Rachel Elsby] [Entered: 05/19/2020 05:38 PM]
May 19, 2020 Filing 34 Entry of appearance for Rachel J. Elsby as principal counsel for Biotechnology Innovation Organization. Service: 05/19/2020 by email. [695775] [20-1723] [Rachel Elsby] [Entered: 05/19/2020 05:35 PM]
May 18, 2020 Opinion or Order Filing 33 ORDER filed. Amarins motion is granted [ # 8 ] to the extent that Amarins opening brief is due no later than May 12, 2020, Appellees response brief(s) are due no later than June 16, 2020, Amarins reply brief is due no later than June 26, 2020, and the joint appendix is due no later than July 1, 2020. The appeal will be placed on the next available oral argument calendar once briefing is complete. Hikmas motion is granted [ # 28 ] to the extent that the revised official caption is reflected in the order. Service as of this date by the Clerk of Court. [695259] [NL] [Entered: 05/18/2020 11:43 AM]
May 12, 2020 Filing 32 MODIFIED ENTRY: CORRECTED BRIEF FILED for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Number of Pages: 72. Service: 05/12/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [694092] --[Edited 05/19/2020 by LMN - compliance review complete] [Jonathan Singer] [Entered: 05/12/2020 06:18 PM]
May 12, 2020 Filing 31 Notice of Correction to Doc No. [ # 30 ] for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 05/12/2020 by email. [694091] [20-1723] [Jonathan Singer] [Entered: 05/12/2020 06:14 PM]
May 12, 2020 Filing 30 FILED from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Title: OPENING BRIEF. Service: 05/12/2020 by email. This document has been corrected. See doc. [ # 32 ] [694048] [20-1723]--[Edited 05/19/2020 by LMN] [Jonathan Singer] [Entered: 05/12/2020 04:09 PM]
May 1, 2020 Filing 29 Entry of appearance for Caroline Sun as of counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 05/01/2020 by email. [691719] [20-1723] [Caroline Sun] [Entered: 05/01/2020 03:21 PM]
May 1, 2020 Filing 28 MOTION of Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. to modify the official caption [Consent: unopposed]. Service: 05/01/2020 by email. [691561] [20-1723] [Charles Klein] [Entered: 05/01/2020 10:22 AM]
April 30, 2020 Filing 27 Corrected Certificate of Interest for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/30/2020 by email. [691123] [20-1723] [Constance Huttner] [Entered: 04/30/2020 09:40 AM]
April 28, 2020 Filing 26 Entry of appearance for James P. Barabas as of counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/28/2020 by email. [690562] [20-1723] [James Barabas] [Entered: 04/28/2020 03:05 PM]
April 28, 2020 Filing 25 Entry of appearance for Beth Finkelstein as of counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/28/2020 by email. [690560] [20-1723] [Beth Finkelstein] [Entered: 04/28/2020 03:02 PM]
April 28, 2020 Filing 24 Certificate of Interest for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/28/2020 by email. [690556] [20-1723] [Constance Huttner] [Entered: 04/28/2020 02:59 PM]
April 28, 2020 Filing 23 Docketing Statement for the Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/28/2020 by email. [690553] [20-1723] [Constance Huttner] [Entered: 04/28/2020 02:57 PM]
April 28, 2020 Filing 22 Entry of appearance for Constance S. Huttner as principal counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/28/2020 by email. [690550] [20-1723] [Constance Huttner] [Entered: 04/28/2020 02:54 PM]
April 27, 2020 Filing 21 Corrected Entry of appearance for Eric Sonnenschein as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/27/2020 by email. [690368] [20-1723] [Eric Sonnenschein] [Entered: 04/27/2020 04:56 PM]
April 27, 2020 Filing 20 Corrected Entry of appearance for Jeffrey Elikan as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/27/2020 by email. [690364] [20-1723] [Christopher Sipes] [Entered: 04/27/2020 04:46 PM]
April 27, 2020 Filing 19 Corrected Entry of appearance for Christopher Sipes as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/27/2020 by email. [690360] [20-1723] [Christopher Sipes] [Entered: 04/27/2020 04:36 PM]
April 27, 2020 Filing 18 NOTICE OF NON-COMPLIANCE: The submission of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited, Entries of Appearance [ # 9 ], [ # 10 ], [ # 11 ], is not in compliance with the rules of this court (see attached). Compliant documents are due on 05/04/2020. Service as of this date by the Clerk of Court. [690250] [LMN] [Entered: 04/27/2020 02:26 PM]
April 24, 2020 Filing 17 Entry of appearance for Eimeric Reig-Plessis as of counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689811] [20-1723] [Eimeric Reig-Plessis] [Entered: 04/24/2020 12:59 PM]
April 24, 2020 Filing 16 Entry of appearance for Alison M. Heydorn as of counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689809] [20-1723] [Alison Heydorn] [Entered: 04/24/2020 12:57 PM]
April 24, 2020 Filing 15 Entry of appearance for Claire A. Fundakowski as of counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689805] [20-1723] [Claire Fundakowski] [Entered: 04/24/2020 12:53 PM]
April 24, 2020 Filing 14 Certificate of Interest for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689803] [20-1723] [Charles Klein] [Entered: 04/24/2020 12:51 PM]
April 24, 2020 Filing 13 Docketing Statement for the Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689800] [20-1723] [Charles Klein] [Entered: 04/24/2020 12:49 PM]
April 24, 2020 Filing 12 Entry of appearance for Charles B. Klein as principal counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689797] [20-1723] [Charles Klein] [Entered: 04/24/2020 12:45 PM]
April 24, 2020 Filing 11 Entry of appearance for Christopher Sipes as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/24/2020 by email. [689739] [20-1723] This document is non-compliant. See Doc No.[ # 18 ] [Christopher Sipes] [Entered: 04/24/2020 11:10 AM]
April 24, 2020 Filing 10 Entry of appearance for Jeffrey Elikan as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/24/2020 by email. [689737] [20-1723] This document is non-compliant. See Doc No.[ # 18 ] [Jeffrey Elikan] [Entered: 04/24/2020 11:05 AM]
April 24, 2020 Filing 9 Entry of appearance for Eric Sonnenschein as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/24/2020 by email. [689729] [20-1723] This document is non-compliant. See Doc No.[ # 18 ] [Eric Sonnenschein] [Entered: 04/24/2020 10:53 AM]
April 22, 2020 Filing 8 MOTION of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited to expedite briefing schedule, to expedite hearing [Consent: unopposed]. Service: 04/22/2020 by email. [689057] [20-1723] [Jonathan Singer] [Entered: 04/22/2020 10:23 AM]
April 21, 2020 Filing 7 Entry of appearance for Oliver Richards as of counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688767] [20-1723] [Oliver Richards] [Entered: 04/21/2020 02:11 PM]
April 21, 2020 Filing 6 Entry of appearance for Nitika Gupta Fiorella as of counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688765] [20-1723] [Nitika Gupta Fiorella] [Entered: 04/21/2020 02:07 PM]
April 21, 2020 Filing 5 Entry of appearance for Deanna J. Reichel as of counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688762] [20-1723] [Deanna Reichel] [Entered: 04/21/2020 02:03 PM]
April 21, 2020 Filing 4 Docketing Statement for the Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688761] [20-1723] [Jonathan Singer] [Entered: 04/21/2020 02:00 PM]
April 21, 2020 Filing 3 Certificate of Interest for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688760] [20-1723] [Jonathan Singer] [Entered: 04/21/2020 01:57 PM]
April 21, 2020 Filing 2 Entry of appearance for Jonathan E. Singer as principal counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688758] [20-1723] [Jonathan Singer] [Entered: 04/21/2020 01:55 PM]
April 21, 2020 Filing 1 Appeal docketed. Received: 04/14/2020. [688590] Entry of Appearance is due 05/05/2020. Certificate of Interest is due on 05/05/2020. Docketing Statement is due 05/05/2020. Appellant's brief is due 06/22/2020. [LMN] [Entered: 04/21/2020 09:54 AM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Search for this case: Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellant: AMARIN PHARMACEUTICALS IRELAND LIMITED
Represented By: Oliver Richards
Represented By: Deanna Jean Reichel
Represented By: Nitika Gupta Fiorella
Represented By: Jonathan Elliot Singer
Represented By: Jeffrey B. Elikan
Represented By: Christopher Neil Sipes Esq.
Represented By: Eric Ritland Sonnenschein
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellant: AMARIN PHARMA, INC.
Represented By: Oliver Richards
Represented By: Deanna Jean Reichel
Represented By: Nitika Gupta Fiorella
Represented By: Jonathan Elliot Singer
Represented By: Jeffrey B. Elikan
Represented By: Christopher Neil Sipes Esq.
Represented By: Eric Ritland Sonnenschein
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellee: DR. REDDY'S LABORATORIES, LTD.
Represented By: Beth C. Finkelstein
Represented By: James Barabas
Represented By: Constance Huttner
Represented By: Caroline Sun
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellee: WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED
Represented By: Claire A. Fundakowski
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellee: DR. REDDY'S LABORATORIES, INC.
Represented By: Beth C. Finkelstein
Represented By: James Barabas
Represented By: Constance Huttner
Represented By: Caroline Sun
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellee: HIKMA PHARMACEUTICALS USA INC.
Represented By: Alison Michelle Heydorn
Represented By: Claire A. Fundakowski
Represented By: Eimeric Reig-Plessis
Represented By: Charles B. Klein
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellee: HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED
Represented By: Alison Michelle Heydorn
Represented By: Claire A. Fundakowski
Represented By: Eimeric Reig-Plessis
Represented By: Charles B. Klein
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Amicus curiae: AIMED ALLIANCE
Represented By: Paul Alessio Mezzina
Represented By: Ashley Charles Parrish
Represented By: Jesse Snyder
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Amicus curiae: BIOTECHNOLOGY INNOVATION ORGANIZATION
Represented By: Hansjorg Sauer Ph.D.
Represented By: Melissa A. Brand Esq.
Represented By: Rachel J. Elsby
Represented By: Jason Weil
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?